sur DIAGNOSTIC MEDICAL (EPA:ALDMS)
Strengthening Governance at DMS Group: Julien Delpech Appointed Independent Director
On June 17, 2025, DMS Group announced a change in its governance structure. At the Annual General Meeting on June 16, 2025, shareholders approved the appointment of Julien Delpech as an independent director. Delpech, 51, is known for his career in online continuing medical education, notably as the founder of Invivox.
He joins the Board of Directors alongside members such as Marie-Laurence Borie, Léone Atayi, and Jean-François Gendron. Delpech's arrival coincides with the departure of Régis Roche from his role as director. Roche, however, remains a significant shareholder in the company. This strengthening of governance comes as DMS Group continues to expand its activities in the medical imaging sector, both in France and internationally.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de DIAGNOSTIC MEDICAL